These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 18309714)

  • 1. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of serum lipids in leprosy.
    Gupta A; Koranne RV; Kaul N
    Indian J Dermatol Venereol Leprol; 2002; 68(5):262-6. PubMed ID: 17656962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte arginase activity in leprosy--a preliminary report.
    Babu CS; Kannan KB; Bharadwaj VP; Katoch VM
    Indian J Med Res; 1990 May; 91():193-6. PubMed ID: 2397940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histopathological correlation in the classification of leprosy.
    Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased lipid peroxidation in lepromatous leprosy.
    Bhadwat VR; Borade VB
    Indian J Dermatol Venereol Leprol; 2000; 66(3):121-5. PubMed ID: 20877051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HIV infection on the clinical spectrum of leprosy in Maiduguri.
    Moses AE; Adelowo KA; Nwankwo EA
    Niger Postgrad Med J; 2001 Jun; 8(2):74-7. PubMed ID: 11487905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase activity in leprosy (a preliminary study).
    Chaudhary SD; Gupta V; Saini AS; Singh V; Lal H
    Indian J Lepr; 1988 Jan; 60(1):17-20. PubMed ID: 3204272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of serum zinc level in leprosy.
    Saxena N; Sharma RP; Singh VS
    Indian J Lepr; 1988 Oct; 60(4):556-61. PubMed ID: 3253334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis-B virus infection in patients with leprosy--a brief communication.
    Katoch VM; Katoch K; Dutta AK; Sharma VD; Ramu G
    Lepr India; 1983 Apr; 55(2):193-6. PubMed ID: 6632778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis.
    Ozgocmen S; Kaya H; Fadillioglu E; Yilmaz Z
    Arch Med Res; 2007 Feb; 38(2):196-205. PubMed ID: 17227729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of melatonin on experimental otitis media with effusion in guinea pigs.
    Ucuncu H; Aktan B; Ozabacigil F; Buyukokuroglu ME; Akyuz M; Altas E
    Ann Clin Lab Sci; 2004; 34(3):341-6. PubMed ID: 15487711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
    Daniel E; Koshy S; Joseph GA; Rao PS
    Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.